FIH Study to Evaluate Safety, Tolerability, PK, PD & Preliminary Efficacy of AT03-65 With Advanced Solid Tumors
Clinical trial NCT06809114 · RECRUITING
Trial details
- NCT number
- NCT06809114
- Sponsor
- Axcynsis Therapeutics Pte Ltd
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-14
- Primary completion
- 2027-12-01
- Enrollment
- 83
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.